Decheng Capital China Life Sciences USD Fund II, L.P.
CIK 1650291 · last filed 2025-10-20
Decheng Capital China Life Sciences USD Fund II, L.P. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $1.6M of BYSI on Oct 20, 2025. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.46M
1
7
-$2.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYSI | 10%+ Owner | 1,564,406 | $1.57 | $2.46M | -$2.12M | 7 | 2025-10-20 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-20 | BYSI | Sell (S) | −919,177 | -$1.59M | EDGAR |
| 2025-10-07 | BYSI | Sell (S) | −141,400 | -$251.8K | EDGAR |
| 2025-09-29 | BYSI | Sell (S) | −10,800 | -$18.3K | EDGAR |
| 2025-09-16 | BYSI | Sell (S) | −24,660 | -$45.6K | EDGAR |
| 2025-09-08 | BYSI | Sell (S) | −53,994 | -$103.2K | EDGAR |
| 2025-09-03 | BYSI | Sell (S) | −29,220 | -$52.0K | EDGAR |
| 2025-08-15 | BYSI | Sell (S) | −29,400 | -$58.8K | EDGAR |